MODIFICATION OF KERATIN BY THE CHEMOTHERAPEUTIC DRUG MITOXANTRONE

被引：13

作者：

CRESS, AE

ROBERTS, RA

BOWDEN, GT

DALTON, WS

机构：

来源：

BIOCHEMICAL PHARMACOLOGY | 1988年 / 37卷 / 15期

关键词：

D O I：

10.1016/0006-2952(88)90296-1

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：3043 / 3046

页数：4

共 30 条

[1]

ALBERTS DS, 1985, INVEST NEW DRUG, V3, P101

[2]

BASRA J, 1985, ANTI-CANCER DRUG DES, V1, P45

[3]

BOWDEN GT, 1985, CANCER RES, V45, P4915

[4]

BOWDEN GT, 1982, CANCER RES, V42, P2660

[5]

CLARKSON TW, 1984, CYTOSKELETON TARGET

[6] A COMPARATIVE-ANALYSIS OF DRUG-INDUCED DNA EFFECTS IN A NITROGEN-MUSTARD RESISTANT CELL-LINE EXPRESSING SENSITIVITY TO NITROSOUREAS [J].

DEAN, SW ;

JOHNSON, AB ;

TEW, KD .

BIOCHEMICAL PHARMACOLOGY, 1986, 35 (07) :1171-1176

[7] HOMOLOGY BETWEEN P-GLYCOPROTEIN AND A BACTERIAL HEMOLYSIN TRANSPORT PROTEIN SUGGESTS A MODEL FOR MULTIDRUG RESISTANCE [J].

GERLACH, JH ;

ENDICOTT, JA ;

JURANKA, PF ;

HENDERSON, G ;

SARANGI, F ;

DEUCHARS, KL ;

LING, V .

NATURE, 1986, 324 (6096) :485-489

[8] THE CDNA SEQUENCE OF A TYPE-II CYTOSKELETAL KERATIN REVEALS CONSTANT AND VARIABLE STRUCTURAL DOMAINS AMONG KERATINS [J].

HANUKOGLU, I ;

FUCHS, E .

CELL, 1983, 33 (03) :915-924

[9] IDENTIFICATION OF 2 TYPES OF KERATIN POLYPEPTIDES WITHIN THE ACIDIC CYTOKERATIN SUBFAMILY .1. [J].

JORCANO, JL ;

RIEGER, M ;

FRANZ, JK ;

SCHILLER, DL ;

MOLL, R ;

FRANKE, WW .

JOURNAL OF MOLECULAR BIOLOGY, 1984, 179 (02) :257-281

[10] AMINO-ACID SEQUENCE DIVERSITY BETWEEN BOVINE EPIDERMAL CYTOKERATIN POLYPEPTIDES OF THE BASIC (TYPE-II) SUBFAMILY AS DETERMINED FROM CDNA CLONES [J].

JORCANO, JL ;

FRANZ, JK ;

FRANKE, WW .

DIFFERENTIATION, 1984, 28 (02) :155-163

← 1 2 3 →